Mark Collingbourne
Finanzdirektor/CFO bei INTUITIVE INVESTMENTS GROUP PLC
Vermögen: 133 049 $ am 31.05.2024
Profil
Mark Kingsley Collingbourne is currently working as a Secretary at Optibiotix Health Plc, Chief Financial Officer at Intuitive Investments Group Plc, and Chief Finance Officer at ProBiotix Health Plc.
Previously, he worked as a Secretary & Finance Director at ViaLogy Plc in 2014, Finance Director at Curtis Brown Group Ltd.
from 1996 to 2001, Non-Executive Director at Orogen Plc, Chief Financial Officer, Secretary & Director at Yourgene Health Plc from 2014 to 2015, Secretary, Director & Finance Director at REACT Group Plc from 2015 to 2017, and Secretary, Director & Finance Director at Sosandar Plc from 2017 to 2022.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SOSANDAR PLC
0,37% | 31.03.2023 | 928 919 ( 0,37% ) | 133 049 $ | 31.05.2024 |
Aktive Positionen von Mark Collingbourne
Unternehmen | Position | Beginn |
---|---|---|
OPTIBIOTIX HEALTH PLC | Unternehmenssekretär | - |
INTUITIVE INVESTMENTS GROUP PLC | Finanzdirektor/CFO | - |
ProBiotix Health Plc
ProBiotix Health Plc Pharmaceuticals: OtherHealth Technology ProBiotix Health Plc. engages in the development of probiotic products for cardiovascular disease and other lifestyle conditions. It operates under the following geographical segments: UK, US, and Rest of World. The company was founded by Stephen Patrick O'Hara in 2018 and is headquartered in Wakefield, the United Kingdom. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Mark Collingbourne
Unternehmen | Position | Ende |
---|---|---|
SOSANDAR PLC | Finanzdirektor/CFO | 05.05.2021 |
REACT GROUP PLC | Finanzdirektor/CFO | 11.09.2017 |
YOURGENE HEALTH | Finanzdirektor/CFO | 04.06.2015 |
Curtis Brown Group Ltd.
Curtis Brown Group Ltd. Media ConglomeratesConsumer Services Curtis Brown Group Ltd. operates as entertainment agency. The company was founded by Albert Curtis Brown in 1899 and is headquartered in London, the United Kingdom. | Finanzdirektor/CFO | 01.01.2001 |
Orogen Plc
Orogen Plc Financial ConglomeratesFinance Orogen Plc provides financial support for its mineral exploration activities as a shell company. It holds interest in Deli Jovan and Mutsk Gold projects. The company was founded on March 2, 2005 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
OPTIBIOTIX HEALTH PLC | Health Technology |
REACT GROUP PLC | Consumer Services |
SOSANDAR PLC | Retail Trade |
INTUITIVE INVESTMENTS GROUP PLC | Finance |
Health Technology |
Private Unternehmen | 4 |
---|---|
ViaLogy Plc
ViaLogy Plc Electronic Equipment/InstrumentsElectronic Technology ViaLogy Plc provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. Its product, QuantumRD, is a new technology for the discovery, validation, and recovery of oil and gas reservoirs. The company was founded in 1999 and is headquartered in Gifford, the United Kingdom. | Electronic Technology |
Curtis Brown Group Ltd.
Curtis Brown Group Ltd. Media ConglomeratesConsumer Services Curtis Brown Group Ltd. operates as entertainment agency. The company was founded by Albert Curtis Brown in 1899 and is headquartered in London, the United Kingdom. | Consumer Services |
Orogen Plc
Orogen Plc Financial ConglomeratesFinance Orogen Plc provides financial support for its mineral exploration activities as a shell company. It holds interest in Deli Jovan and Mutsk Gold projects. The company was founded on March 2, 2005 and is headquartered in London, the United Kingdom. | Finance |
Yourgene Health Plc
Yourgene Health Plc Medical SpecialtiesHealth Technology Yourgene Health Plc engages in the development and commercialization of genomic services and technologies. It primarily manufactures molecular diagnostic solutions for reproductive health, precision medicine and infectious diseases. It operates through the Genomic Technologies and Genomic Services segments. The Genomic Technologies segment represents the in vitro diagnostic products, software and instrumentation manufactured by the group. The Genomic Services segment operates testing laboratories in Taiwan and the UK, and provides services to clinicians, third party clinical service providers and contract research organizations. The company was founded on April 13, 2000 and is headquartered in Manchester, the United Kingdom. | Health Technology |